An interventional study of COVID-19 Testing Home-based (Aim 1) and COVID-19 Testing Mobile (Aim 1) in Covid19, sponsored by San Diego State University. Completed at 1 site in United States. Open to participants aged 6 Years to 120 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-14.
Sponsored by San Diego State University · Not applicable, Interventional, and Health services research
To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.
Communities Fighting COVID is a partnership between San Diego State's School of Public Health and numerous communities in San Diego focused on providing community-based testing to specific language-speaking communities and vulnerable populations. This partnership is funded by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics-Undeserved Populations (Radx-UP), with the aim of ensuring all Americans have access to timely COVID-19 testing and diagnosis. Many communities, particularly immigrant and people of color communities, have a harder time accessing existing COVID-19 resources due to transportation, language barriers, or other barriers.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 32,750 is above the median of 100 across 4,099 interventional studies indexed under COVID-19.
Browse COVID-19 studies →San Diego State University is the lead sponsor of 145 studies on the registry; 41 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
High-risk friends and family of contacts exposed to COVID-19 will be provided with COVID-19 testing provided at home by a healthcare worker.
Other: COVID-19 Testing Home-based (Aim 1)
High-risk friends and family of contacts exposed to COVID-19 will be referred to study operated mobile testing sites in the community for COVID-19 testing.
Other: COVID-19 Testing Mobile (Aim 1)
Mobile testing utilizing active outreach
Other: COVID-19 Testing Mobile Approach 1 (Aim 2)
Mobile testing utilizing baseline outreach approaches
Other: COVID-19 Testing Mobile Approach 2 (Aim 2)
Implementation of Antigen and PCR testing at participant homes
Implementation of Antigen and PCR testing at mobile test sites
Implementation of Antigen and PCR testing at mobile test sites - active outreach
Implementation of Antigen and PCR testing at mobile test sites - baseline outreach
Test uptake
Testing volume by study arm as cumulative count per hours testing site operated
Time frame: Through study completion, expected to be 20 months
Test access
Proportion of individuals by study arm who note that this strategy has facilitated ability to test.
Time frame: Through study completion, expected to be 20 months
Test Impact (COVID-19 diagnoses)
Proportion of COVID-19 diagnoses of those tested by study arm
Time frame: Through study completion, expected to be 20 months
Test Impact (number needed to screen)
Number needed to screen (number tested in order to detect one new infection).
Time frame: Through study completion, expected to be 20 months
Plan to share: Yes — Plan to share with Rad-X UP Coordinating Center
Supporting information: Study protocol, Sap
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
San Diego State University